Sale!

RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility Type 4 NGS Genetic DNA Test

Original price was: R9,350.Current price is: R6,700.

-28%

Facing concerns about hereditary breast or ovarian cancer in your family? Our RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility Type 4 NGS Genetic DNA Test provides the clarity you need for just R6,700. This advanced Next-Generation Sequencing test specifically examines the RAD51D gene mutation that significantly increases your lifetime risk of developing breast and ovarian cancers. If you have a family history of these cancers, especially among close relatives, this test offers life-changing insights. Our comprehensive approach includes genetic counselling to create your family pedigree chart, ensuring you understand your results in context. With results in 3-4 weeks and nationwide coverage including Johannesburg, Cape Town, and Durban, taking control of your health has never been more accessible. Early detection through genetic testing can guide proactive health decisions and potentially save lives.

📞 24/7 South African Support Team Call : +27 6412 56421

  • ✓ ISO Accredited Lab Reports
  • ✓ Free Genetic Counseling Included
  • 🔒 100% Confidential & Secure Testing
Guaranteed Safe Checkout

RAD51D Gene Cancer Test R6
RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility Type 4 NGS Genetic DNA Test
R9,350 Original price was: R9,350.R6,700Current price is: R6,700.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Take Control of Your Genetic Cancer Risk with the RAD51D Gene Test

When cancer runs in your family, the uncertainty can feel overwhelming. Many South African women worry about their genetic predisposition to breast and ovarian cancers, especially when they’ve seen loved ones face these challenges. Our RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility Type 4 NGS Genetic DNA Test provides the answers you need to make informed health decisions and potentially prevent cancer before it develops.

Understanding Your RAD51D Genetic Cancer Risk

The RAD51D gene plays a crucial role in repairing DNA damage in your cells. When this gene contains specific mutations, it significantly increases your lifetime risk of developing breast and ovarian cancers. Our advanced Next-Generation Sequencing (NGS) technology examines your RAD51D gene with exceptional accuracy, identifying mutations that could impact your health and your family’s future.

This isn’t just another medical test – it’s a powerful tool for proactive health management that can guide your screening schedule, preventive measures, and family planning decisions.

Who Should Consider This Genetic Cancer Test?

This test is particularly important if you identify with any of these situations:

  • Multiple family members diagnosed with breast or ovarian cancer
  • Breast cancer diagnosed before age 50 in close relatives
  • Ovarian cancer at any age in your family history
  • Both breast and ovarian cancer in the same relative
  • Male breast cancer in your family
  • Ashkenazi Jewish ancestry with cancer history
  • Personal history of breast cancer before age 45

If you’ve been carrying the weight of family cancer history, this test can provide the clarity needed to move forward with confidence.

Why Early Genetic Detection Matters for Your Health

Knowing your RAD51D status empowers you to take proactive steps that could save your life:

  • Personalised Screening: Tailor your mammogram and ultrasound schedule based on your actual risk
  • Preventive Options: Discuss risk-reducing medications or surgeries with your doctor
  • Family Planning: Make informed decisions about your reproductive future
  • Peace of Mind: Reduce anxiety by replacing uncertainty with knowledge
  • Family Awareness: Help relatives understand their own cancer risks

Early detection through genetic testing transforms fear into actionable health strategies.

Understanding Your Test Results

We understand that waiting for genetic test results can be stressful. Our process is designed to provide clarity and support:

  • Positive Result: If a RAD51D mutation is found, our genetic counsellors will explain what this means for your cancer risk and connect you with specialists for personalised management plans
  • Negative Result: No RAD51D mutation detected means your cancer risk returns to population levels, though continued screening is still recommended
  • Variant of Uncertain Significance: Sometimes we find genetic changes whose impact isn’t yet fully understood – we’ll monitor these and update you as research progresses

Regardless of your results, you’ll receive comprehensive guidance on next steps and ongoing support.

Transparent Pricing – Investing in Your Health Future

Service Regular Price Special Price Value
RAD51D Gene Test ZAR 9,350 ZAR 6,700 Save ZAR 2,650
Genetic Counselling Session Included at no extra cost
Family Pedigree Analysis Included in your comprehensive package

Consider this: The cost of cancer treatment can exceed ZAR 500,000. Investing ZAR 6,700 in prevention could save not only money but potentially your life.

Why Trust Oracle Genomics with Your Genetic Health?

  • Nationwide Coverage: Accessible testing centres in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
  • Medical Expertise: Oncologist-supervised testing with genetic counselling included
  • Advanced Technology: Next-Generation Sequencing ensures 99.9% accuracy
  • Quick Turnaround: Results in 3-4 weeks with clear explanations
  • Multiple Sample Options: Blood, extracted DNA, or simple finger-prick blood spot
  • Comprehensive Preparation: Clinical history review and family pedigree analysis included

Take the First Step Toward Genetic Clarity Today

Don’t let family cancer history dictate your future. With our special pricing of ZAR 6,700 (regularly ZAR 9,350), there’s never been a better time to understand your genetic cancer risk.

Limited Availability: Our genetic counselling sessions fill quickly. Book now to secure your preferred appointment time in Johannesburg, Cape Town, Durban or your nearest location.